ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,672Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 198

$851K Total Retail Price of All Prescriptions

Rank: 14 out of 198

509 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 17,061 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 949 878 1 1
SIMVASTATIN 781 685 2 2
SPIRONOLACTONE 696 637 3 37
OMEPRAZOLE 680 619 4 3
WARFARIN SODIUM 578 554 5 7
METFORMIN HCL 401 376 6 13
TORSEMIDE 379 366 7 75
LISINOPRIL 356 309 8 6
ALLOPURINOL 348 304 9 23
AMLODIPINE BESYLATE 338 316 10 4
NAMENDA 301 301 11 33
CITALOPRAM HBR 293 273 12 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 281 263 13 38
METOLAZONE 278 263 14 121
BYSTOLIC 270 257 15 58
ALENDRONATE SODIUM 266 238 16 21
METOPROLOL SUCCINATE 219 206 17 11
ATORVASTATIN CALCIUM 218 205 18 12
CRESTOR 206 197 19 26
POLYETHYLENE GLYCOL 3350 204 186 20 41
OXYCODONE-ACETAMINOPHEN 203 177 S2 21 79
FUROSEMIDE 196 189 22 5
GLIMEPIRIDE 190 167 23 35
ZOLPIDEM TARTRATE 175 149 24 22
ATENOLOL 164 147 25 17
NEXIUM 157 123 26 40
CLONIDINE HCL 155 155 27 52
GABAPENTIN 154 151 28 14
TRAMADOL HCL 149 144 29 15
VESICARE 138 138 30 77
HYDROCHLOROTHIAZIDE 138 129 30 16
FINASTERIDE 133 133 32 94
METOPROLOL TARTRATE 133 126 32 10
CIPROFLOXACIN HCL 132 128 34 55
PRAVASTATIN SODIUM 131 119 35 19
AZITHROMYCIN 131 121 35 56
DIOVAN HCT 126 116 37 88
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 113 38 90
AMITRIPTYLINE HCL 122 104 R 39 69
TRAMADOL HCL-ACETAMINOPHEN 122 113 39 185
POTASSIUM CHLORIDE 121 103 41 9
CARVEDILOL 120 120 42 24
CARBIDOPA-LEVODOPA 115 107 43 71
DIOVAN 114 105 44 34
ISOSORBIDE MONONITRATE ER 109 97 45 60
ADVAIR DISKUS 108 100 46 47
FENTANYL 108 84 S2 46 73
PREDNISONE 107 94 48 29
TAMSULOSIN HCL 105 92 49 27
EVISTA 105 105 49 104
CYCLOBENZAPRINE HCL 102 77 R 51 67
SERTRALINE HCL 101 97 52 25
SYNTHROID 101 95 52 36
AMIODARONE HCL 95 82 54 119
LANTUS 88 71 55 46
NITROFURANTOIN 86 85 56 213
EXELON 85 85 57 123
DONEPEZIL HCL 85 85 57 28
AMLODIPINE BESYLATE-BENAZEPRIL 85 85 57 99
AVODART 84 63 60 184
ESCITALOPRAM OXALATE 83 73 61 53
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 62 49
FLUTICASONE PROPIONATE 80 80 62 39
MELOXICAM 79 44 64 30
DIGOXIN 77 71 65 43
SINGULAIR 76 62 66 106
HYDROCODONE-ACETAMINOPHEN 76 60 S3 66 8
DICYCLOMINE HCL 74 73 68 214
MUPIROCIN 71 70 69 216
URSODIOL 68 53 70 252
DIVALPROEX SODIUM 68 68 70 122
MIRTAZAPINE 66 66 72 44
CEFDINIR 66 60 72 254
PREMARIN 65 45 R 74 101
PRAMIPEXOLE DIHYDROCHLORIDE 63 63 75 157
TRICOR 59 59 76 93
AMOX TR-POTASSIUM CLAVULANATE 58 52 77 154
LOSARTAN POTASSIUM 57 57 78 18
RAMIPRIL 57 57 78 72
CEPHALEXIN 57 51 78 108
ZETIA 56 32 81 68
HUMULIN 70-30 54 39 82 192
LEVOTHROID 54 54 82 195
RANITIDINE HCL 53 40 84 54
RISPERIDONE 53 49 84 82
NAPROXEN 53 52 84 133
CLOPIDOGREL 52 46 87 42
DOXYCYCLINE HYCLATE 52 47 87 97
INSULIN SYRINGE 52 51 87 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.